AerSale Corporation
NASDAQ:ASLEAirlines, Airports & Air Services
-$0.11 today
- Market cap
- $242.47M
- Beta
- 0.27
- P/E (TTM)
- 25.5
- EPS (TTM)
- $0.25
Volume 0.30M
Average 0.37M
ASLE Other Financing Activities
Financing cash flows not reported separately.
AerSale CorporationNASDAQ: ASLE
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities turns positive
Q1 FY2026 other financing activities was $0, compared with -$159K a year earlier. Trailing-twelve-month other financing activities was $189K. Over 3 fiscal years it compounded at -73.8% a year.
Context
- Other financing activities amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Other financing activities grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other financing activities holds near $0 or moves back toward the trailing-twelve-month quarterly average of $47.25K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (37K) USD
- Year-over-year change
- +85.2%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (37K) | +85.2% |
| FY2024 | 2024-12-31 | (250K) | +96.4% |
| FY2023 | 2023-12-31 | (7.02M) | -241.7% |
| FY2022 | 2022-12-31 | (2.05M) | -196.0% |
| FY2021 | 2021-12-31 | (694K) | — |
Other Financing Activities vs competitors
How ASLE compares with its peers on the latest reported figures
- ASLE's LTM Mar 2026 other financing activities of $189K is the smallest of the 11 companies compared; the peer median is $301.54K.
- Its year-over-year change of +298.9% is the 4th highest of 11, against a peer median of -13.7%.
- Other financing activities amounts to 0.1% of revenue for ASLE, versus a peer median of 2.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $52.25M | +712.5% | +202.8% | 12.8% | |
| LTM Mar 2026 | $20.48M | +78680.8% | — | 27.9% | |
| LTM Mar 2026 | $19.12M | -48.7% | — | 30.1% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $10.44M | -4.9% | — | 6.2% |
| LTM Mar 2026 | $9.25M | +99.1% | — | 2.1% | |
| LTM Mar 2026 | $8M | -61.4% | +47.7% | 0.4% | |
| LTM Mar 2026 | $6.59M | -89.7% | — | 1.7% | |
| LTM Mar 2026 | $3.34M | -22.5% | — | 0.6% | |
| LTM Mar 2026 | $391.9K | +9897.4% | — | — | |
| LTM Mar 2026 | $211.18K | -98.9% | — | 0.1% | |
| LTM Mar 2026 | $189K | +298.9% | -73.8% | 0.1% | |
| Peer median (excluding ASLE) | $301.54K | -13.7% | +125.2% | 2.1% | |
Competitors are the stored peer set for ASLE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 36.12M | 43.86M | (5.56M) | 5.85M | 8.58M |
| Depreciation & Amortization | 13M | 11.86M | 10.82M | 16.41M | 19.89M |
| Deferred Income Tax | (3.19M) | (2.39M) | (916K) | 2.03M | 1.39M |
| Stock-Based Compensation | 12.72M | 16.5M | 12.05M | 4.35M | 4.89M |
| Change in Working Capital | 12.51M | (72.07M) | (190.18M) | (19.39M) | (61.49M) |
| Accounts Receivables | (3.34M) | (1.03M) | (4.59M) | (3.97M) | (7.74M) |
| Inventory | (35.67M) | (37.64M) | (168.63M) | (78.03M) | (54.8M) |
| Accounts Payables | 3.6M | 1.16M | 8.77M | 4.29M | (4.54M) |
| Other Working Capital | 47.92M | (34.56M) | (25.72M) | 58.32M | 5.59M |
| Other Non-Cash Items | 7.92M | 2.12M | (363K) | 1.93M | 3.78M |
| Operating Cash Flow | 79.08M | (113K) | (174.15M) | 11.18M | (22.97M) |
| Capital Expenditures | (3.89M) | (15.6M) | (11.36M) | (29.03M) | (6.08M) |
| Acquisitions (Net) | 17.1M | 0 | 14.45M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 56.97M | 0 | 12.9M | 2.22M |
| Investing Cash Flow | 13.2M | 41.37M | 3.09M | (16.13M) | (3.86M) |
| Debt Repayment | 0 | 0 | 36.2M | 3.49M | 71.16M |
| Common Stock Issued | 9.28M | 0 | 566K | 531K | 386K |
| Common Stock Repurchased | 0 | (22.2M) | 0 | 0 | (45M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (694K) | (2.05M) | (7.02M) | (250K) | (37K) |
| Financing Cash Flow | 8.59M | (24.26M) | 29.74M | 3.77M | 26.51M |
| Effect of Forex Changes | (1) | 0 | 0 | 0 | 0 |
| Net Change in Cash | 100.87M | 17M | (141.32M) | (1.18M) | (319K) |
| Free Cash Flow | 75.19M | (15.71M) | (185.51M) | (17.85M) | (29.05M) |
AerSale Corporation
NASDAQ:ASLE
Intrinsic Alpha fair value
Locked
Current Price
$5.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.